Revolving Door Phenomenon

Former FDA Biologics Chief Peter Marks Joins Eli Lilly to Lead Infectious Disease and Molecule Discovery

The move, six months after his clash with HHS Secretary Robert F. Kennedy Jr., has revived scrutiny of the regulator-to-industry pipeline.